Skip to main content

Biomarkers – The key to early cancer detection and patient outcomes

By March 8, 2024No Comments

Cancer remains a formidable global challenge, with its incidence on the rise. Early detection plays a pivotal role in mitigating its impact, offering higher survival rates, less invasive treatments, and reduced emotional burden. This co-publication with CAS, offers a comprehensive overview of cancer biomarkers and their critical role in early detection, providing valuable insights for researchers, healthcare professionals, and stakeholders in the fight against cancer.

Key Highlights:

  • Understanding the significance of cancer biomarkers in early detection and treatment.
  • Analyzing trends in biomarker research, including types, techniques, and clinical applications.
  • Exploring the challenges and opportunities in biomarker development and validation.
  • Showcasing real-world data insights from CAS Content Collection™ and Excelra’s Biomarker Insights dataset.
  • Highlighting promising biomarkers for pancreatic and liver cancers, two challenging-to-detect malignancies.

Download the Publication Now to Uncover the Latest Insights in Cancer Biomarkers and Their Impact on Early Detection and Treatment.


Note: This publication is a collaborative effort between CAS, a division of the American Chemical Society, and Excelra Knowledge Solutions Pvt. Ltd. All rights reserved. No part of this report may be reproduced or distributed without prior written permission.

Please fill the form

"*" indicates required fields

This will close in 0 seconds